[Noleptan in chronic lung diseases].
D000813:Anilides / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D004341:Drug Evaluation; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008744:Methylamines / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012507:Sarcoidosis / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000813:Anilides; D000996:Antitussive Agents; D008744:Methylamines; D009025:Morpholines
Noleptan bei chronischen Lungenkrankheiten